074 A Multicentre, Open-Label, Long-Term Extension Study in Patients with Moderate-to-Severe Rheumatoid Arthritis from the Summacta and Brevacta Studies: Evaluation of the Safety and Efficacy of Subcutaneous Tocilizumab